Form Type: 4

SEC EDGAR Link
Accession Number:0000899243-21-031258
Date:2021-07-30
Issuer: SOLENO THERAPEUTICS INC (SLNO)
Original Submission Date:

Reporting Person:

HARRIS WILLIAM G
203 REDWOOD SHORES PKWY, STE 500
REDWOOD CITY, CA 94065

Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
Title of SecurityTransaction Date2a. Deemed Execution Date Transaction CodeSharesAcquired or DisposedPrice per share 5. Amount of Securities Beneficially Owned Following Reported Transaction 6. Ownership Form Direct or IndirectNature of Indirect Ownership
COMMON STOCK 2021-07-30 A 16,484 a $0.00 96,032 direct
COMMON STOCK 2021-07-30 F 5,210 d $0.91 90,822 direct
Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, convertible securities
Title of Derivative Security Conversion or Exercise Price of Derivative Security Transaction Date Deemed Execution Date Transaction Code Number of Derivative Securities Acquired (A) or Disposed of (D) Date ExercisableExpiration Date Title and Amount of Securities Underlying Derivative Security Price of Derivative Security Number of derivative Securities Beneficially Owned Following Reported Transaction(s) Ownership Form: Direct (D) or Indirect (I) Nature of Indirect Beneficial Ownership
Footnotes
IDfootnote
f1 the reported securities are represented by restricted stock units ("rsus"). each rsu represents a contingent right to receive one share of slno common stock. the rsus are fully vested on july 30, 2021.
f2 represents shares that have been withheld by the issuer to satisfy its tax withholding and remittance obligations in connection with the net settlement of restricted stock units and does not represent a sale by the reporting person.
WhaleWisdom Logo

Elevate your investments